1. "Hematologic Malignancies Research"
Formats
  1. Journal Article (1521)
  2. Meeting Abstract (1232)
  3. Review (76)
  4. Editorial (34)
  5. Book Section (32)
  6. Research Letter (25)
  7. Conference Paper (15)
  8. Correspondence (7)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (2950)
  2. Hematologic Malignancies Research (2950)
  3. GSK Faculty (2412)
  4. Department of Medicine (2277)
  5. Hematologic Malignancies, Division of (2078)
  6. Sloan Kettering Institute Faculty (2026)

More Groups

People
  1. Michel Sadelain (582)
  2. David Scheinberg (499)
  3. Alexander Lesokhin (363)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (279)

More People

Years
  1. 2025 (32)
  2. 2024 (108)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (636)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (108)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (674)
  2. Nature Publishing Group (367)
  3. Elsevier Inc. (290)
  4. American Association for Cancer Research (245)
  5. Cell Press (116)
  6. American Society of Clinical Oncology (112)

More Publishers

Results (2950)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells
    Journal Article

    Wang, Y.; Yen, F. S.; Zhu, X. G.; Timson, R. C.; Weber, R.; Xing, C.; Liu, Y.; Allwein, B.; Luo, H.; Yeh, H. W.; more...
    Nature (2021)

    Fulltext@MSK | Save
  • Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease
    Meeting Abstract

    Avecilla, S.; Boulad, F.; Yazdanbakhsh, K.; Sadelain, M.; Shi, P. A.
    Transfusion (2021)

    Fulltext@MSK | Save
  • Evidence for continued dose escalation of plerixafor for hematopoietic progenitor cell collections in sickle cell disease
    Meeting Abstract

    Boulad, F.; Zhang, J.; Yazdanbakhsh, K.; Sadelain, M.; Shi, P. A.
    Transfusion (2021)

    Fulltext@MSK | Save
  • Human cytomegalovirus expands a CD8(+) T cell population with loss of BCL11B expression and gain of NK cell identity
    Journal Article

    Sottile, R.; Panjwani, M. K.; Lau, C. M.; Daniyan, A. F.; Tanaka, K.; Barker, J. N.; Brentjens, R. J.; Sun, J. C.; Le Luduec, J. B.; Hsu, K. C.
    Science Immunology (2021)

    Fulltext@MSK | Save
  • SnapShot: Cancer metabolism
    Miscellaneous

    Brunner, J. S.; Finley, L. W. S.
    Molecular Cell (2021)

    Fulltext@MSK | Save
  • Fate mapping of single NK cells identifies a type 1 innate lymphoid-like lineage that bridges innate and adaptive recognition of viral infection
    Journal Article

    Flommersfeld, S.; Böttcher, J. P.; Ersching, J.; Flossdorf, M.; Meiser, P.; Pachmayr, L. O.; Leube, J.; Hensel, I.; Jarosch, S.; Zhang, Q.; more...
    Immunity (2021)

    Fulltext@MSK | Save
  • T cells critically depend on pyruvate oxidation
    Editorial

    Schrecker, C.; Intlekofer, A. M.
    Cell Metabolism (2021)

    Fulltext@MSK | Save
  • Oncogenic HSP90 facilitates metabolic alterations in aggressive B-cell lymphomas
    Journal Article

    Calvo-Vidal, M. N.; Zamponi, N.; Krumsiek, J.; Stockslager, M. A.; Revuelta, M. V.; Phillip, J. M.; Marullo, R.; Tikhonova, E.; Kotlov, N.; Patel, J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • MagnetisMM-1: A study of elranatamab (PF-06863135), a B-cell maturation antigen (BCMA)-targeted, CD3-engaging bispecific antibody, for patients with relapsed or refractory multiple myeloma (MM)
    Meeting Abstract

    Levy, M.; Bahlis, N.; Raje, N.; Costello, C.; Dholaria, B.; Solh, M.; Tomasson, M.; Dube, H.; Damore, M.; Lon, H. K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • A tumor-agnostic TCR-mimic CAR-T cell specific for NDC80 targets multiple hematological malignancies
    Meeting Abstract

    Klatt, M. G.; Dao, T.; Yang, Z.; Liu, J.; Mun, S. S.; Dacek, M. M.; Luo, H.; Gardner, T. J.; Bourne, C.; Peraro, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save